×
img

Citi花旗银行:2024年GLP-1受体激动剂对肥胖症及其他病症的影响研究报告(英文版)

发布者:wx****73
2024-11-20
3 MB 76 页
医疗
文件列表:
Citi花旗银行:2024年GLP-1受体激动剂对肥胖症及其他病症的影响研究报告(英文版).pdf
下载文档

GLP-1 ‘wonder-drugs’ have crashed into the collective consciousness in recent months. Claims about easy weight loss have clogged our social media feeds. A tribe of followers has emerged. A hype cycle has developed. What’s the substance behind the hype around these drugs--which have in fact been around for several years? And what impact could they have on the global battle against obesity and beyond, in places you might not have thought about yet? In this Citi GPS report we’ll look at some of


加载中...

本文档仅能预览20页

继续阅读请下载文档

网友评论>

开通智库会员享超值特权
专享文档
免费下载
免广告
更多特权
立即开通

发布机构

更多>>